{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-005468","form_type":"8-K","ticker":"OPK","cik":"0000944809","company_name":"OPKO HEALTH, INC.","filed_at":"2025-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.894704+00:00","generated_at":"2026-05-26T03:00:27.029340+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"OPKO Health reports Q4 net income of $14M, revenue $183.6M; BARDA/Merck milestones boost pharma","bullets":["Consolidated Q4 revenue $183.6M vs $181.9M; net income $14.0M ($0.01 diluted EPS) vs net loss of $66.5M in Q4 2023.","Pharma segment operating loss narrowed to $2.1M from $16.0M; IP transfer revenue rose to $43.1M (includes $12.5M Merck milestone, $23.8M BARDA).","Diagnostics revenue fell to $103.1M from $124.2M on asset sales; operating loss improved to $21.7M from $42.3M.","BARDA awarded additional $51M for COVID/influenza antibodies; total awards to ModeX now $110M, up to $205M if all options exercised.","Capital actions: repurchased $17M principal notes, 10.9M shares for $16.5M; reduced share count 10% in 2024; sold part of BioReference for $237.5M."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-005468","json":"https://secwatch.observer/filing/0001437749-25-005468.json","markdown":"https://secwatch.observer/filing/0001437749-25-005468.md","text":"https://secwatch.observer/filing/0001437749-25-005468.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/944809/000143774925005468/0001437749-25-005468-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/944809/000143774925005468/opk20250103_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T03:00:27.029340+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}